EN DE
STOCK COMPARISON

Withuspharmaceutical Co.Ltd vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Withuspharmaceutical Co.Ltd (330350) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Withuspharmaceutical Co.Ltd as the less overvalued of the two: Withuspharmaceutical Co.Ltd trades at KRW 7,250 versus a fair value of KRW 5,955 (-18%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).
Withuspharmaceutical Co.Ltd
330350.KQ · KRW · Energy
-18%
upside to fair value
overvalued
PriceKRW 7,250
Fair ValueKRW 5,955
Quality61/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-52%
upside to fair value
overvalued
Price¥54.18
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Withuspharmaceutical Co.LtdJiangsu Hengrui Medicine Co
Valuation
P/E (TTM)43.6×
P/S (TTM)10.84×
P/B5.76×
EV/EBITDA33.0×
PEG0.93×
Dividend yield0.4%
Dividend per share¥0.20
Profitability
7%Net margin25%
1%Operating margin32%
7%Return on equity15%
2%Return on assets9%
Growth
10%Revenue growth (YoY)13%
18.1%Avg. growth/yr (3Y)13.9%
32.3%Avg. growth/yr (5Y)2.5%
Balance & size
0.02×Debt / equity
$58MMarket cap$52B
healthyGrowth qualityhealthy

Jiangsu Hengrui Medicine Co leads: 2 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Withuspharmaceutical Co.Ltdof which business quality 60 · market factors 27 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 47
ProfitabilityMargins and returns on capital today
48
63
Quality GrowthAre margins and returns improving?
49
41
CashflowEarnings quality: real cash, not paper profit
38
82
Fin. StrengthBalance sheet, leverage, solvency risk
77
100
InvestmentDisciplined investing over empire-building
81
27
Low VolatilityCalm price path (market factor)
43
78
MomentumPrice trend over the last 3–12 months (market factor)
18
37
52W MomentumDistance to the 52-week high (market factor)
25
29
Net IssuanceBuybacks instead of dilution
82
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Withuspharmaceutical Co.Ltd

DCF ModelsKRW 8,494
Earnings-BasedKRW 6,115
Dividend DiscountKRW 1,758
MultiplesKRW 5,984
Asset-BasedKRW 4,975
Growth DCFKRW 8,845
Economic ProfitKRW 5,129
Growth EarningsKRW 7,562

14 of 26 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Withuspharmaceutical Co.Ltd
Bear KRW 5,143Fair Value KRW 5,955Bull KRW 6,585
KRW 7,250 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.18 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Withuspharmaceutical Co.Ltd · Energy

Quality score61 · Top 25%
Fair value upside-18% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-52% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Withuspharmaceutical Co.Ltd as the less overvalued of the two: Withuspharmaceutical Co.Ltd trades at KRW 7,250 versus a fair value of KRW 5,955 (-18%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.